Muscle Mass Assessed by the D3-Creatine Dilution Method and Incident Self-reported Disability and Mortality in a Prospective Observational Study of Community-Dwelling Older Men

Abstract
Whether low muscle mass is a risk factor for disability and mortality is unclear. Associations between approximations of muscle mass (including lean mass from dual energy x-ray absorptiometry (DXA)) and these outcomes are inconsistent. Muscle mass measured by deuterated creatine (D3Cr) dilution and appendicular lean mass (ALM, by DXA) were assessed at the Year 14 Visit (2014-6) of the prospective MrOS study (N=1425, age 77-101 years). Disability in activities of daily living (ADLs), instrumental ADLS (IADLs), and mobility tasks was self-reported at the Year 14 visit and 2.2 years later; deaths were centrally adjudicated over 3.3 years. Relative risks (RR) and 95% confidence intervals (CI) were estimated per standard deviation decrement with negative binomial, logistic regression or proportional hazards models. In age and clinical center adjusted models, the RR per decrement in D3Cr muscle mass/wgt was 1.9 (95% CI: 1.2, 3.1) for incident self-reported ADL disability; 1.5 (95% CI: 1.3, 1.9) for IADL disability; and 1.8 (95% CI: 1.5, 2.2) for mobility disability. In age, clinical center and weight adjusted models, the RR per decrement in D3Cr muscle mass was 1.8 (95% CI: 1.5, 2.2) for all-cause mortality. In contrast, lower DXA ALM was not associated with any outcome. Associations of D3Cr muscle mass with these outcomes were slightly attenuated after adjustment for confounding factors and the potentially mediating effects of strength and physical performance. Low muscle mass as measured by D3Cr dilution is a novel risk factor for clinically meaningful outcomes in older men.
Funding Information
  • National Institutes of Health
  • National Institute on Aging
  • National Center for Advancing Translational Sciences
  • NIH Roadmap for Medical Research (U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, UL1 TR000128)
  • NIAMS (R01 AR065268)